Ubs Asset Management Americas Inc Tarsus Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 86,378 shares of TARS stock, worth $5.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86,378
Previous 71,220
21.28%
Holding current value
$5.22 Million
Previous $3.66 Million
4.35%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TARS
# of Institutions
215Shares Held
46.3MCall Options Held
7.8KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$197 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$188 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$180 Million5.63% of portfolio
-
Jennison Associates LLC2.47MShares$149 Million0.06% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$148 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.61B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...